| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |